Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Community Allies
  • Our Work
    • Advancing Research
    • Changing Policy
    • Evolving Education
    • The Virtual Trip
  • News
    • Updates
    • Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Volunteer
    • Careers
    • Community Events
    • Resources
    • Integration Station
    • Music Is the Bridge
  • Store
    • Learning
    • Apparel
    • Accessories
    • Bookshop
Login
  • Donate
0

Newsletters

Letter from the Chief Editor: A Major Shift for the Bulletin

December 20, 2024 Hi friend, It’s been 36 years since MAPS launched its first edition of the Bulletin in 1988. There have been 34 editions and around 1,400 published articles, and we’ve provided knowledge …

A Message To Our Supporters On the U.S. Election

November 6, 2024 Dear MAPS Supporters, Though we are disappointed that Massachusetts voters chose not to establish safe, legal, and regulated access to psychedelics this year, we are grateful to the advocates …

MAPS Comment to Reagan Udall on Advancing Psychedelic Therapies

Dear MAPS community and supporters, On September 6th, the Reagan Udall Foundation hosted a public meeting on advancing treatments for PTSD, where psychedelic therapies were a significant part of the discussion. …

Q&A with Benjamin De Loenen

Benjamin De Loenen is the Executive Director of The International Center for Ethnobotanical Education, Research, and Service (ICEERS), a fiscal sponsee of MAPS dedicated to transforming society’s relationship …

Expert Insights on FDA’s Recent PTSD Treatment Meeting

Dear MAPS community and supporters, We’re excited to share insights from the U.S. Food and Drug Administration (FDA) hybrid public meeting, Advancing Treatments for Post-Traumatic Stress Disorder (PTSD). …

FDA Decision, Redoubling of MAPS Efforts, and Lykos Board Resignation

Dear MAPS community and supporters, These have been very challenging times at MAPS, at Lykos, in the entire psychedelic ecosystem, and in the world at large. Personally, I’ve been working at MAPS for …

A note from Rick on today’s news from the FDA

Our collective commitment to MDMA-assisted therapy remains unwavering Dear friends, I wanted you and all of our supporters to hear from us: today, Lykos Therapeutics announced that the U.S. Food and Drug …

Rally with Veterans to Advocate for MDMA Therapy Approval

Our friends at Healing Breakthrough, Heroic Hearts, and The Mission Within are calling on us to take action! We need to share our voices in support of Veterans and others suffering from PTSD. Millions …

Educating Mental Healthcare Providers Worldwide

In 2023, MAPS established an international therapist education program to equip care providers with theoretical fundamentals and best practices in psychedelic-assisted therapies. These education programs …

Gratitude, Celebration, and Great Promise

Dear MAPS supporter, It’s with profound gratitude to the thousands of people in the MAPS community who selflessly contributed in any way over the decades to bring us to this point that I share some triumphant …

Newsletter: February 2023

MAPS published our first email newsletter in 2003, and since then a lot has changed! The psychedelic community has grown exponentially, psychedelic research is being conducted by many groups around the …

Newsletter: January 2023

Prior Positive Results Confirmed in MAPS-Sponsored, Philanthropy-Funded Phase 3 January 26, 2023 In monumental psychedelic news, on January 5, we confirmed prior positive results in our philanthropy-funded …

Posts pagination

Page 1 … Page 20 Next Page
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
    • Global Affiliates
  • Our Work
    • Psychedelic Fundamentals
    • The Virtual Trip
    • U.S. MDMA Therapy Education
    • Health Equity
    • Policy & Advocacy
  • Advancing Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.
Proudly powered by WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide